THALASSEMIA AND VENOUS THROMBOEMBOLISM

Julien Succar, Khaled M. Musallam, Ali T Taher
  • Julien Succar
    Affiliation not present
  • Khaled M. Musallam
    Affiliation not present

Abstract

Although the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. In this review, the molecular and cellular mechanisms leading to hypercoagulability in thalassemia are highlighted, with a special focus on thalassemia intermedia being the group with the highest incidence of thrombotic events as compared to other types of thalassemia. Clinical experience and available clues on optimal management are also discussed

Full Text:

PDF
HTML
Submitted: 2014-06-12 16:02:49
Published: 2011-05-25 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
1337

Views:
PDF
142
HTML
4216

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy